HYSI, ALBANA
 Distribuzione geografica
Continente #
NA - Nord America 220
EU - Europa 129
AS - Asia 117
SA - Sud America 7
AF - Africa 1
Totale 474
Nazione #
US - Stati Uniti d'America 218
CN - Cina 35
TR - Turchia 33
IE - Irlanda 28
SG - Singapore 28
SE - Svezia 27
UA - Ucraina 23
IT - Italia 19
GB - Regno Unito 13
DE - Germania 8
IN - India 7
BR - Brasile 6
VN - Vietnam 6
RU - Federazione Russa 4
FI - Finlandia 3
FR - Francia 3
IR - Iran 3
MY - Malesia 3
MX - Messico 2
CO - Colombia 1
IL - Israele 1
KZ - Kazakistan 1
RO - Romania 1
SN - Senegal 1
Totale 474
Città #
Chandler 42
Jacksonville 35
Dublin 28
Izmir 20
Dearborn 19
Singapore 18
Nanjing 13
Princeton 12
Southend 10
Ashburn 8
Beijing 8
Wilmington 7
Woodbridge 7
Altamura 6
Cambridge 6
Dong Ket 6
Boardman 5
Ardabil 3
Kuala Lumpur 3
Leawood 3
Los Angeles 3
Nanchang 3
Ann Arbor 2
Augusta 2
Grevenbroich 2
Monmouth Junction 2
Norwalk 2
Santa Clara 2
Seattle 2
Washington 2
Araraquara 1
Buffalo 1
Changchun 1
Changsha 1
Chicago 1
Chieti 1
Concord 1
Dakar 1
Guangzhou 1
Hangzhou 1
Hebei 1
Helsinki 1
Houston 1
Jiaxing 1
Kunming 1
Lucknow 1
Manaus 1
Miami 1
Milford 1
Navegantes 1
New York 1
Oral 1
Petrolina 1
Porteirão 1
Quzhou 1
San Mateo 1
Santa Fe 1
Santo Antônio do Descoberto 1
Shenyang 1
St Louis 1
The Dalles 1
Udine 1
Yinchuan 1
Totale 314
Nome #
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 95
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 95
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 82
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 80
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 77
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 73
Totale 502
Categoria #
all - tutte 1.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 5 0 16 0 1 9 0 0 0 1 12 9
2021/202217 0 0 0 0 0 0 0 0 1 2 6 8
2022/2023122 8 22 10 10 15 16 9 8 14 5 2 3
2023/202444 0 1 5 2 4 10 12 2 1 2 0 5
2024/202563 8 11 8 1 3 2 1 6 8 4 8 3
Totale 502